APA (7th ed.) Citation

J, B., C, E., WF, P., VS, M., & JB, Y. (2004). The efficacy and safety of B-type natriuretic peptide (nesiritide) in patients with renal insufficiency and acutely decompensated congestive heart failure. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 19(2), 391. https://doi.org/10.1093/ndt/gfg558

Chicago Style (17th ed.) Citation

J, Butler, Emerman C, Peacock WF, Mathur VS, and Young JB. "The Efficacy and Safety of B-type Natriuretic Peptide (nesiritide) in Patients with Renal Insufficiency and Acutely Decompensated Congestive Heart Failure." Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association 19, no. 2 (2004): 391. https://doi.org/10.1093/ndt/gfg558.

MLA (9th ed.) Citation

J, Butler, et al. "The Efficacy and Safety of B-type Natriuretic Peptide (nesiritide) in Patients with Renal Insufficiency and Acutely Decompensated Congestive Heart Failure." Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association, vol. 19, no. 2, 2004, p. 391, https://doi.org/10.1093/ndt/gfg558.